P Shepherd

588 total citations
15 papers, 388 citations indexed

About

P Shepherd is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, P Shepherd has authored 15 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in P Shepherd's work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). P Shepherd is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). P Shepherd collaborates with scholars based in United Kingdom and Germany. P Shepherd's co-authors include Nicholas C.P. Cross, Andreas Reiter, Rüdiger Hehlmann, Andreas Hochhaus, Heyko Skladny, Frits van Rhee, N. C. Allan, JM Goldman, Feng Lin and David J. Harrison and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

P Shepherd

15 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Shepherd United Kingdom	8	329	259	159	71	47	15	388
D.-W. Kim South Korea	5	527 1.6×	406 1.6×	252 1.6×	90 1.3×	24 0.5×	5	590
Elisa Zuffa Italy	8	212 0.6×	214 0.8×	92 0.6×	17 0.2×	18 0.4×	26	313
María Soledad Undurraga Chile	4	425 1.3×	361 1.4×	212 1.3×	47 0.7×	43 0.9×	9	460
Juan Julio Kassack Ipiña Mexico	4	418 1.3×	366 1.4×	210 1.3×	53 0.7×	41 0.9×	5	471
Perttu Koskenvesa Finland	12	366 1.1×	291 1.1×	129 0.8×	40 0.6×	40 0.9×	29	461
Cheryl Boyd United States	6	350 1.1×	174 0.7×	47 0.3×	83 1.2×	16 0.3×	6	399
Dushyant Verma United States	10	415 1.3×	289 1.1×	112 0.7×	75 1.1×	48 1.0×	14	486
Emilia Scalzulli Italy	10	271 0.8×	159 0.6×	52 0.3×	28 0.4×	25 0.5×	60	358
Arta Dreimane Sweden	9	296 0.9×	246 0.9×	123 0.8×	50 0.7×	45 1.0×	17	347
Nelma Cristina D. Clementino Brazil	8	293 0.9×	231 0.9×	132 0.8×	39 0.5×	27 0.6×	16	312

Countries citing papers authored by P Shepherd

Since Specialization

Citations

This map shows the geographic impact of P Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Shepherd more than expected).

Fields of papers citing papers by P Shepherd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Shepherd. The network helps show where P Shepherd may publish in the future.

Co-authorship network of co-authors of P Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of P Shepherd. A scholar is included among the top collaborators of P Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Shepherd. P Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Clark, Richard E., Tessa L. Holyoake, Jenny Byrne, et al.. (2011). Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed. Haematologica. 96(12). 1779–1782. 15 indexed citations

Milojković, Dragana, Emma Nicholson, Jane F. Apperley, et al.. (2009). Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Haematologica. 95(2). 224–231. 80 indexed citations

Shepherd, P, et al.. (2009). Systemic mastocytosis presenting as osteoporosis—a case report. Clinical Rheumatology. 28(7). 865–866. 7 indexed citations

Shepherd, P, et al.. (2008). Successful Use of National Cancer Registry Data to Monitor the Effective Use of Imatinib for Treating Chronic Myeloid Leukaemia. Scottish Medical Journal. 53(3). 8–12. 2 indexed citations

Feng, Liang, Mark W. Drummond, Jenny Byrne, et al.. (2002). Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.. Blood. 100(11). 1425. 7 indexed citations

Shepherd, P, et al.. (2001). A randomised comparison of low or high dose IFN-alpha in newly diagnosed CML patients shows no difference in major cytogenetic response rate or survival between the two groups - Results of MRC CML V & HOVON 20 trials.. Blood. 98(11). 3 indexed citations

Hochhaus, Andreas, Feng Lin, Andreas Reiter, et al.. (1996). Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood. 87(4). 1549–1555. 138 indexed citations

Hochhaus, Andreas, Feng Lin, Andreas Reiter, et al.. (1995). Variable numbers of BCR‐ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon‐α. British Journal of Haematology. 91(1). 126–131. 58 indexed citations

Allan, N. C., et al.. (1993). United Kingdom Medical Research Council Randomized Trial of Interferon Alfa in Chronic-Phase Chronic Myelogenous Leukemia.. PubMed. 30(3 Suppl 3). 20–1. 4 indexed citations

10.

Shepherd, P, et al.. (1992). Molecular breakpoints and platelet counts in chronic myeloid leukemia [letter; comment]. Blood. 80(2). 556–557. 1 indexed citations

11.

Hamilton, Malcolm, P Shepherd, John B. Porter, & John Richards. (1992). Granulocytic Sarcomas of Small Intestine and Brain are Associated with Acute Myelomonocytic Leukaemia with Abnormal Eosinophils and Inversion of Chromosome 16. Leukemia & lymphoma. 8(4-5). 409–413. 13 indexed citations

12.

Shepherd, P, et al.. (1992). Molecular breakpoints and platelet counts in chronic myeloid leukemia [letter; comment]. Blood. 80(2). 556–557. 13 indexed citations

13.

Shepherd, P, J. Fooks, Richard Gray, & N. C. Allan. (1991). Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non‐cirrhotic portal hypertension. RESULTS FROM MRC CML II TRIAL COMPARING BUSULPHAN WITH BUSULPHAN AND THIOGUANINE. British Journal of Haematology. 79(2). 185–192. 23 indexed citations

14.

Shepherd, P & David J. Harrison. (1990). Idiopathic portal hypertension associated with cytotoxic drugs.. Journal of Clinical Pathology. 43(3). 206–210. 21 indexed citations

15.

Shepherd, P, et al.. (1989). Early delayed radiation injury to the brainstem after radiotherapy for lymphoma of the tongue and neck. Clinical Oncology. 1(2). 110–114. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact